Having identified community-driven post-approval drug surveillance as one of its goals, CTAC chose to bring a community-based research approach to the issues of Post Approval Surveillance System (PASS) the system tracking adverse drug events after the drug goes to market.

How We Came To This PASS: the current post-approval surveillance system in Canada (.PDF) (Background fact sheet).

The PASS Study: A Brief Overview (.PDF) Summary fact sheet).

The PASS Study : A Report to the Community (.PDF) (Plain language synthesis report).